Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Thames Water picks KKR as preferred partner

(Sharecast News) - Thames Water has selected US investment firm KKR to take a stake in the business, as the utility desperately works to avoid renationalisation amid eye-watering bill increases for its long-suffering customers. Britain's biggest water supplier is labouring under a £19bn debt pile and needs fresh cash.

"The company remains focused on putting Thames Water on a more stable financial foundation, implementing its turnaround plan and delivering a market-led solution that is in the best interests of customers, UK taxpayers and the wider economy," the company said in a statement on Monday.

Rocked by a series of scandals, ranging from sewage spills into rivers and streams and billions in dividend payouts to investors, Thames has also faced a barrage of criticism for landing customers with an almost 40% increase in annual bills this year despite no end to leaks and disruption. Meanwhile, the company's chief financial officer Alastair Cochran quit on Friday.

KKR, which is already a minority shareholder in Northumbrian Water, was among several companies interested in partnering with Thames. Five others expressed an interest, according to the company.

Thames said the KKR proposal includes financial metrics "which indicate a material impairment of the Class A debt" meaning repayments to senior bondholders may take a hit.

"There is no certainty that a binding equity proposal will be forthcoming as it remains subject to diligence, documentation and regulatory and other approvals. As a result, certain senior creditors continue to progress in parallel alternative transaction structures to seek to recapitalise the business," Thames added.

Two weeks ago it won approval from the court of appeal for a £3bn emergency debt bailout from its existing creditors to avoid being placed into a special administration regime, which is a form of temporary nationalisation.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.